Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3366)
All Articles published online
|
Oct 7, 2005 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pongchairerk U, Guan JL, Leardkamolkarn V. Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1. World J Gastroenterol 2005; 11(37): 5845-5852 [PMID: 16270396 DOI: 10.3748/wjg.v11.i37.5845] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i37/5845.htm |
| Number | Citing Articles |
| 1 |
Sang-Hyun Lee, Jin-Man Kim, Dong Gwang Lee, Jangwook Lee, Jong-Gil Park, Tae-Su Han, Hyun-Soo Cho, Young-Lai Cho, Kwang-Hee Bae, Young-Jun Park, Seon-Jin Lee, Moo-Seung Lee, Yong-Min Huh, Deog Yeon Jo, Hwan-Jung Yun, Heung Jin Jeon, Nayoung Kim, Mina Joo, Jang-Seong Kim, Hyo Jin Lee, Jeong-Ki Min. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation. Cell Death & Differentiation 2021; 28(3): 968 doi: 10.1038/s41418-020-00628-4
|
| 2 |
Audrey Clapéron, Martine Mergey, Thanh Huong Nguyen Ho-Bouldoires, Danijela Vignjevic, Dominique Wendum, Yves Chrétien, Fatiha Merabtene, Alexandra Frazao, Valérie Paradis, Chantal Housset, Nathalie Guedj, Laura Fouassier. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. Journal of Hepatology 2014; 61(2): 325 doi: 10.1016/j.jhep.2014.03.033
|
| 3 |
Wen-Sheng Wu, Chin-Hsien Ling, Ming-Che Lee, Chuan-Chu Cheng, Rui-Fang Chen, Chen-Fang Lin, Ren-In You, Yen-Cheng Chen. Targeting Src-Hic-5 Signal Cascade for Preventing Migration of Cholangiocarcinoma Cell HuCCT1. Biomedicines 2022; 10(5): 1022 doi: 10.3390/biomedicines10051022
|
| 4 |
Jessica E. Hall, Wei Fu, Michael D. Schaller. . International Review of Cell and Molecular Biology 2011; 288: 185 doi: 10.1016/B978-0-12-386041-5.00005-4
|
| 5 |
Dietmar W. Siemann, Meiyu Dong, Chris Pampo, Wenyin Shi. Src-signaling interference impairs the dissemination of blood-borne tumor cells. Cell and Tissue Research 2012; 349(2): 541 doi: 10.1007/s00441-012-1415-7
|
| 6 |
Giuliana Cavalloni, Caterina Peraldo-Neia, Ivana Sarotto, Loretta Gammaitoni, Giorgia Migliardi, Marco Soster, Serena Marchiò, Massimo Aglietta, Francesco Leone. Antitumor Activity of Src Inhibitor Saracatinib (AZD-0530) in Preclinical Models of Biliary Tract Carcinomas. Molecular Cancer Therapeutics 2012; 11(7): 1528 doi: 10.1158/1535-7163.MCT-11-1020
|
| 7 |
Wen-Sheng Wu, Rui-Fang Chen, Chuan-Chu Cheng, Jia-Ling Wei, Chen-Fang Lin, Ren-In You, Yen-Chang Chen, Ming-Che Lee, Yen-Cheng Chen. Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma. Pharmaceutics 2022; 14(12): 2698 doi: 10.3390/pharmaceutics14122698
|
| 8 |
Jhang Ho Pak, Qudsia Bashir, In Ki Kim, Sung-Jong Hong, Sejung Maeng, Young Yil Bahk, Tong-Soo Kim. Clonorchis sinensis excretory-secretory products promote the migration and invasion of cholangiocarcinoma cells by activating the integrin β4–FAK/Src signaling pathway. Molecular and Biochemical Parasitology 2017; 214: 1 doi: 10.1016/j.molbiopara.2017.03.002
|
| 9 |
Yanyan Shi, Ying Wei, Ting Zhang, Jing Zhang, Ye Wang, Shigang Ding. Deoxycholic Acid Could Induce Apoptosis and Trigger Gastric Carcinogenesis on Gastric Epithelial Cells by Quantitative Proteomic Analysis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9638963
|
| 10 |
Putthaporn Kaewmeesri, Piman Pocasap, Veerapol Kukongviriyapan, Auemduan Prawan, Sarinya Kongpetch, Laddawan Senggunprai. Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein. Integrative Cancer Therapies 2022; 21: 153473542211248 doi: 10.1177/15347354221124861
|
| 11 |
Jörg H. Leupold, Irfan Asangani, Gabriele D. Maurer, Ernst Lengyel, Stefan Post, Heike Allgayer. Src Induces Urokinase Receptor Gene Expression and Invasion/Intravasation via Activator Protein-1/p-c-Jun in Colorectal Cancer. Molecular Cancer Research 2007; 5(5): 485 doi: 10.1158/1541-7786.MCR-06-0211
|
| 12 |
Charupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, Sopit Wongkham. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. Scientific Reports 2016; 6(1) doi: 10.1038/srep18995
|
| 13 |
Thannicha Sae-lao, Natthanej Luplertlop, Tavan Janvilisri, Rutaiwan Tohtong, David O. Bates, Kanokpan Wongprasert. Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells. Phytomedicine 2017; 36: 59 doi: 10.1016/j.phymed.2017.09.014
|
| 14 |
Xinhua Song, Hongwei Xu, Pan Wang, Jingxiao Wang, Silvia Affo, Haichuan Wang, Meng Xu, Binyong Liang, Li Che, Wei Qiu, Robert F. Schwabe, Tammy T. Chang, Marion Vogl, Giovanni M. Pes, Silvia Ribback, Matthias Evert, Xin Chen, Diego F. Calvisi. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. Journal of Hepatology 2021; 75(4): 888 doi: 10.1016/j.jhep.2021.05.018
|
| 15 |
Ah-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Do-Youn Oh, Yung-Jue Bang. Src as a Therapeutic Target in Biliary Tract Cancer. Molecular Cancer Therapeutics 2016; 15(7): 1515 doi: 10.1158/1535-7163.MCT-16-0013
|
| 16 |
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2012; 9(1): 44 doi: 10.1038/nrgastro.2011.222
|
| 17 |
Erica L Johnson, Rajesh Singh, Crystal M Johnson-Holiday, William E Grizzle, Edward E Partridge, James W Lillard, Shailesh Singh. CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion. Journal of Ovarian Research 2010; 3(1) doi: 10.1186/1757-2215-3-15
|